The Financial Express - Nov 19, 2007

Ahmedabad-based Marck Biosciences Ltd, engaged in manufacturing of parenterals for domestic and global pharmaceutical companies, forayed into Andhra Pradesh parenterals market. Marck Bio-sciences has initially launched a comprehensive range of quality products in Hyderabad and will roll out all its products across the state by 2007.

"We already have a strong presence in Northand West India and had recently entered the Karnataka market. The launch in Andhra Pradesh is aimed at spear heading our plan 10 crores the target turnover of Rs 100 crore in 2007-08. We are focussing on a dual pronged strategy of domestic market expansion and leveraging the large contract research and manufacturing opportunity to grow exponentially in the coming year," Bhavesh Patel. MD, Marck Bio-sciences said in a release.

In Hyderabad, Marck is targeting revenue of Rs 3 crore by the end of 2007and gain a market share of 25%.

"We are investing Rs 72 crore at our existing manufac­turing facility in Gujarat to in­crease the production capacity to 230 million units of SVP (small volume parenterals) and 61 million units of LVP (large volume parenterals)."

With this, the iota! invest­ment in the Kheda facility would exceed Rs 125 crore. Marck's current production capacity is 65 million units for SVP and 61 million units for LVP.